RHEPA
Regional Health Properties, Inc., together with its subsidiaries, operates as a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living. Its business principally consists of owning and leasing/subleasing of healthcare facilities, including skilled nursing facilities and assisted living facilities to third-party tenants. The c… Read more
RHEPA (RHEPA) - Net Assets
Latest net assets as of September 2025: $3.15 Million USD
Based on the latest financial reports, RHEPA (RHEPA) has net assets worth $3.15 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($72.15 Million) and total liabilities ($69.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.15 Million |
| % of Total Assets | 4.37% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 37.63 |
RHEPA - Net Assets Trend (2020–2024)
This chart illustrates how RHEPA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for RHEPA (2020–2024)
The table below shows the annual net assets of RHEPA from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-2.92K | -101.58% |
| 2023-12-31 | $185.00K | -95.02% |
| 2022-12-31 | $3.72 Million | -64.26% |
| 2021-12-31 | $10.40 Million | -6.38% |
| 2020-12-31 | $11.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to RHEPA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 11327488000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $63.17K | % |
| Other Components | $19.03K | % |
| Total Equity | $-2.92K | 100.00% |
RHEPA Competitors by Market Cap
The table below lists competitors of RHEPA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
XPPE
F:XPPE
|
$378.12K |
|
Lobe Sciences Ltd
OTCQB:LOBEF
|
$378.13K |
|
TUGA Innovations Inc
PINK:TUGAF
|
$378.23K |
|
Aviv Arlon Ltd
TA:AVLN
|
$378.28K |
|
LN Future Invest AB (publ)
ST:LNFI
|
$377.40K |
|
FRESNILLO
BE:FNL
|
$377.32K |
|
Korea Airport Service Co. Ltd.
KQ:005430
|
$377.25K |
|
CIMPRESS (7VP.SG)
STU:7VP
|
$377.04K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in RHEPA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 185,000 to -2,919, a change of -187,919 (-101.6%).
- Net loss of 3,218 reduced equity.
- Other factors decreased equity by 184,701.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.22K | -110.24% |
| Other Changes | $-184.70K | -6327.54% |
| Total Change | $- | -101.58% |
Book Value vs Market Value Analysis
This analysis compares RHEPA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $6.58 | $0.14 | x |
| 2021-12-31 | $5.86 | $0.14 | x |
| 2022-12-31 | $2.09 | $0.14 | x |
| 2023-12-31 | $0.10 | $0.14 | x |
| 2024-12-31 | $-1.57 | $0.14 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently RHEPA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -17.55%
- • Asset Turnover: 0.30x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-460.80%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -6.20% | -3.91% | 0.16x | 9.73x | $-1.80 Million |
| 2021 | -11.37% | -4.43% | 0.25x | 10.17x | $-2.22 Million |
| 2022 | -184.80% | -19.11% | 0.52x | 18.46x | $-7.24 Million |
| 2023 | -2101.62% | -22.65% | 0.28x | 336.11x | $-3.91 Million |
| 2024 | 0.00% | -17.55% | 0.30x | 0.00x | $-2.93K |
Industry Comparison
This section compares RHEPA's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| RHEPA (RHEPA) | $3.15 Million | -6.20% | 21.88x | $377.56K |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |